Information Journal Paper
APA:
CopyGANJAVI, H., GEE, M., NARENDRAN, A., PARKINSON, N., KRISHNAMOORTHY, M., FREEDMAN, M.H., & MALKIN, D.. (2006). ADENOVIRUS-MEDIATED P53 GENE THERAPY IN OSTEOSARCOMA CELL LINES: SENSITIZATION TO CISPLATIN AND DOXORUBICIN. CANCER GENE THERAPY, 13(4), 415-419. SID. https://sid.ir/paper/544086/en
Vancouver:
CopyGANJAVI H., GEE M., NARENDRAN A., PARKINSON N., KRISHNAMOORTHY M., FREEDMAN M.H., MALKIN D.. ADENOVIRUS-MEDIATED P53 GENE THERAPY IN OSTEOSARCOMA CELL LINES: SENSITIZATION TO CISPLATIN AND DOXORUBICIN. CANCER GENE THERAPY[Internet]. 2006;13(4):415-419. Available from: https://sid.ir/paper/544086/en
IEEE:
CopyH. GANJAVI, M. GEE, A. NARENDRAN, N. PARKINSON, M. KRISHNAMOORTHY, M.H. FREEDMAN, and D. MALKIN, “ADENOVIRUS-MEDIATED P53 GENE THERAPY IN OSTEOSARCOMA CELL LINES: SENSITIZATION TO CISPLATIN AND DOXORUBICIN,” CANCER GENE THERAPY, vol. 13, no. 4, pp. 415–419, 2006, [Online]. Available: https://sid.ir/paper/544086/en